PRKCB and peripheral arterial disease: Hyperglycemia was reported to hyperphosphorylated PKCβ in diabetic animal models resulting in impaired ischemia-induced activation of the canonical NF-κβ signaling pathway and inferior experimental PAD outcomes (218).